In this symposium, we explore how the costs and benefits of prevention can be better modeled and estimated and how these can be communicated to policy makers in an effective way.
- Date
- Thursday 3 Oct 2024, 10:00 - 12:30
- Type
- Symposium
- Spoken Language
- English
- Room
- Rotterdam School of Management: J3-43
- Building
- Bayle Building
- Location
- Campus Woudestein
- Ticket information
Physical event only. No fee but registration required and limited capacity.
Health Prevention programs and interventions have the potential to generate substantial societal benefit. These benefits are too often ignored in the policy debate, where the focus tends to be on health care costs only. A motion passed in the Dutch Parliament, as well as several commissions and organizations like the Social Economic Council have urged for a better consideration of benefits and costs of prevention, through the development of adequate models and instruments that introduce these into the policy making process on a regular basis. At the same time, calculating the societal value of prevention measures is hard: many prevention measures cannot be evaluated using randomized trials and the benefits of prevention often only materialize in the long-run and outside of the health care sector.
Michele Cecchini is responsible for the OECD program of work on Public Health and advices policy makers around the world on policies to prevent unhealthy lifestyles and major risk factors. The OECD’s SPHeP model is one of the prime examples of how societal costs and benefits, including long-term macro-economic effects, can be estimated and used to inform policy makers on public health policies. Professor Ardine de Wit, senior researcher at the National Institute for Public Health and the Environment (RIVM), will discuss the recent developments in the Dutch context, following an Expert Committee on the topic and considering the experience of modeling costs and benefits of prevention at the RIVM. Ben Wijnen, who is the head of the Center for Economic Evaluation of the Trimbos institute, will discuss the chances and challenges of evaluating the costs and benefits of specific preventive interventions in practice. A panel with the speakers and additional guests Elena Nixdorf (CPB Netherlands Bureau for Economic Policy) and Albert van der Horst (Ministry of Health), will kick off the discussion with the audience on how to get to better evidence and ultimately better policies in public health.
| Programme | |
|---|---|
| 10.00 | Opening Bram Wouterse and Francisca Vargas Lopes, ESHPM |
| 10.10 | Economic evaluation of prevention and policy-making – an international perspective | Michele Cecchini, OECD |
| 10.35 | Assessing the economic value of prevention – recent developments in the Netherlands | Ardine de Wit, RIVM |
| 11.00 | How we have been doing economic evaluation of prevention – an overview of case-studies | Ben Wijnen, Trimbos |
| 11.25 | Coffee-break |
| 11.45 | Roundtable with Elena Nixdorf (CPB) and Albert van de Horst (Ministry of Health) and discussion |
This symposium is supported by the Erasmus Centre for Health Economics Rotterdam (EsCHER). EsCHER is a leading centre for health economics. It attracts high-quality students, staff, visitors and funds. It also provides excellent research, education and job candidates and actively engages with the public, policymakers and other healthcare stakeholders. We organize events, award ceremony for excellent research and offer scholarship. With more than 100 health economists, EsCHER plays a prominent role in developing and applying methods that contribute to more effective, evidence-based policies and more equitable and efficient healthcare systems.
Registration
- More information
If you have any questions, please contact Francisca Vargas Lopes or Bram Wouterse.
